Capital International Investors Novo Cure LTD Transaction History
Capital International Investors
- $488 Billion
- Q1 2025
A detailed history of Capital International Investors transactions in Novo Cure LTD stock. As of the latest transaction made, Capital International Investors holds 8,945,166 shares of NVCR stock, worth $161 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
8,945,166
Previous 8,873,902
0.8%
Holding current value
$161 Million
Previous $264 Million
39.72%
% of portfolio
0.03%
Previous 0.05%
Shares
24 transactions
Others Institutions Holding NVCR
# of Institutions
266Shares Held
79.4MCall Options Held
970KPut Options Held
118K-
Black Rock Inc. New York, NY12.1MShares$218 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$203 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT5.52MShares$99.4 Million8.14% of portfolio
-
Capital World Investors Los Angeles, CA5.22MShares$93.9 Million0.02% of portfolio
-
State Street Corp Boston, MA2.59MShares$46.6 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.89B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...